← Leaderboards
Holly Rockweiler
Madorra, Inc.
$4,300,000
Attributed
$4,300,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,300,000 · 2
By mechanism
R44$4,300,000 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Estrogens”
- Michael P Harms · Washington University$13,645,932
- Tony Yuen · Icahn School Of Medicine At Mount Sinai$8,061,604
- Tina Garyantes · Linnaeus Therapeutics, Llc$6,999,960
- Ming Xu · University Of Connecticut Sch Of Med/Dnt$4,126,281
- Michael Douglas Nelson · Ut Southwestern Medical Center$3,302,033
- Emily Graves Allen · Emory University$3,291,656
Research focus
EstrogensLubricationCouplingDouble-Blind MethodHormone TherapyLubricantsAdjuvantAbstinenceDevicesCommercializationFeedbackFundingIncidenceIndexingBlood FlowBreast Cancer SurvivorAnatomyCancer RecurrenceAdoptedDesignClient SatisfactionClinical TrialsControl GroupsMedical Device
Grant awards (5)
At-home, ultrasonic device for treatment of vulvovaginal atrophy$485,502
R44 · FY2025 · HD · contact PI
At-home, ultrasonic device for treatment of vulvovaginal atrophy$1,514,498
R44 · FY2024 · HD · contact PI
Developing a novel, non-hormonal treatment paradigm for vaginal dryness in breast cancer survivors$848,452
R44 · FY2021 · CA · contact PI
Developing a novel, non-hormonal treatment paradigm for vaginal dryness in breast cancer survivors$1,151,548
R44 · FY2020 · CA · contact PI
Developing a novel, non-hormonal treatment paradigm for vaginal dryness in breast cancer survivors$300,000
R44 · FY2018 · CA · contact PI